- Home
- CCCC vs SHMD Comparison
CCCC vs SHMD Comparison
Compare CCCC & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- SHMD
- Stock Information
- Founded
- CCCC 2015
- SHMD 1864
- Country
- CCCC United States
- SHMD Germany
- Employees
- CCCC N/A
- SHMD N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- SHMD
- Sector
- CCCC Health Care
- SHMD
- Exchange
- CCCC Nasdaq
- SHMD Nasdaq
- Market Cap
- CCCC 160.1M
- SHMD 179.1M
- IPO Year
- CCCC 2020
- SHMD N/A
- Fundamental
- Price
- CCCC $2.46
- SHMD $4.00
- Analyst Decision
- CCCC Strong Buy
- SHMD
- Analyst Count
- CCCC 4
- SHMD 0
- Target Price
- CCCC $8.50
- SHMD N/A
- AVG Volume (30 Days)
- CCCC 2.9M
- SHMD 91.4K
- Earning Date
- CCCC 11-03-2025
- SHMD 01-01-0001
- Dividend Yield
- CCCC N/A
- SHMD N/A
- EPS Growth
- CCCC N/A
- SHMD N/A
- EPS
- CCCC N/A
- SHMD N/A
- Revenue
- CCCC $34,240,000.00
- SHMD $85,165,542.00
- Revenue This Year
- CCCC N/A
- SHMD N/A
- Revenue Next Year
- CCCC N/A
- SHMD N/A
- P/E Ratio
- CCCC N/A
- SHMD N/A
- Revenue Growth
- CCCC 16.55
- SHMD N/A
- 52 Week Low
- CCCC $1.09
- SHMD $1.86
- 52 Week High
- CCCC $6.52
- SHMD $4.50
- Technical
- Relative Strength Index (RSI)
- CCCC 51.01
- SHMD 64.45
- Support Level
- CCCC $2.31
- SHMD $3.58
- Resistance Level
- CCCC $2.82
- SHMD $4.50
- Average True Range (ATR)
- CCCC 0.22
- SHMD 0.55
- MACD
- CCCC 0.03
- SHMD 0.15
- Stochastic Oscillator
- CCCC 52.41
- SHMD 76.83
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).